BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

BioTech Health X

836 posts

Biotech NewsProstate Cancer Breakthrough: Candel Therapeutic (CADL)’s CAN-2409 Trials Near Completion

  • BioTech Health X
  • December 27, 2024
Candel Therapeutics Inc. (CADL) is a clinical-stage biopharmaceutical company dedicated to revolutionizing cancer treatment through advanced multimodal immunotherapies.…
0 Shares
0
0
0
0
0
0
0

Biotech NewsMonopar Therapeutics (MNPR) Strengthens Financial Stability with $17.7M Public Offering

  • BioTech Health X
  • December 27, 2024
Monopar Therapeutics Inc. (MNPR) is a clinical-stage biotechnology company dedicated to transforming the treatment landscape for rare diseases…
0 Shares
0
0
0
0
0
0
0
CEL-SCI Multikine Phase 3 Data Highlighted at ESMO 2022

Biotech NewsTectonic Therapeutic Reports Strong Q3 2024 Financial Results, $159.1M Cash Reserves

  • BioTech Health X
  • December 27, 2024
Tectonic Therapeutic Inc. (TECX) is a cutting-edge biotechnology company dedicated to pioneering advancements in the discovery and development…
0 Shares
0
0
0
0
0
0
0

Biotech NewsInnoviva (INVA)’s Expanding Portfolio Drives 33% Revenue Growth in Q3 2024

  • BioTech Health X
  • December 26, 2024
Innoviva Inc. (INVA) is a forward-thinking healthcare company dedicated to advancing medical innovation and improving patient outcomes worldwide.…
0 Shares
0
0
0
0
0
0
0

Biotech NewsCollegium (COLL) Reports $9.3M Net Income in Q3 2024 with Record-Breaking Product Sales

  • BioTech Health X
  • December 26, 2024
Collegium Pharmaceutical Inc. (COLL) is a trailblazer in the specialty pharmaceutical industry, dedicated to improving the lives of…
0 Shares
0
0
0
0
0
0
0

Biotech NewsArcutis (ARQT) Achieves $44.8M in Q3 2024 Revenue, Growing 452% Year-Over-Year

  • BioTech Health X
  • December 23, 2024
Arcutis Biotherapeutics Inc. (ARQT) is a commercial-stage biopharmaceutical company dedicated to revolutionizing the treatment of immune-mediated skin diseases.…
0 Shares
0
0
0
0
0
0
0
Biogen Expands Immunology Portfolio with Strategic Acquisition

Biotech NewsAmylyx (AMLX) Reports $234.4M in Cash, Secures Financial Stability Through 2026

  • BioTech Health X
  • December 23, 2024
Amylyx Pharmaceuticals Inc. (AMLX) is a cutting-edge biotechnology company dedicated to developing innovative therapies for neurodegenerative and metabolic…
0 Shares
0
0
0
0
0
0
0

Biotech NewsMiMedx (MDXG) Reports $84M in Q3 2024 Sales, Showcasing Financial Growth

  • BioTech Health X
  • December 22, 2024
MiMedx Group Inc. (MDXG)’s a leading regenerative medicine company specializing in advanced wound care and placental tissue technologies.…
0 Shares
0
0
0
0
0
0
0

Biotech NewsCassava Sciences (SAVA) Secures $149M to Support Simufilam Trials Into 2026

  • BioTech Health X
  • December 22, 2024
Cassava Sciences Inc. (SAVA) is a clinical-stage biotechnology company at the forefront of advancing treatments for Alzheimer’s disease,…
0 Shares
0
0
0
0
0
0
0

Biotech NewsPuma Biotechnology (PBYI) Reports $140.8M NERLYNX® Revenue in 2024 Amid Operational Excellence

  • BioTech Health X
  • December 22, 2024
Puma Biotechnology Inc. (PBYI) is a cutting-edge biopharmaceutical company dedicated to transforming cancer treatment through innovative therapies. Founded…
0 Shares
0
0
0
0
0
0
0

Biotech NewsLakeside Holding (LSH) Deepens Roots in Pharmaceutical Logistics with $1.5M Sinopharm Agreement

  • BioTech Health X
  • December 17, 2024
Lakeside Holding Limited (Nasdaq: LSH) has signed a $1.5 million sales agreement with Sinopharm Holding Hubei New Special…
0 Shares
0
0
0
0
0
0
0

Biotech NewsNeuBase (NBSE)’s PATrOL™ Platform: The Future of RNA-Targeted Therapies

  • BioTech Health X
  • December 15, 2024
NeuBase Therapeutics Inc. (NBSE) is a biotechnology company at the forefront of genetic medicine, leveraging its proprietary PATrOL™…
0 Shares
0
0
0
0
0
0
0

Biotech NewsAnalysts Maintain Optimism as Lexicon Pharmaceuticals (LXRX) Focuses on Long-Term Growth

  • BioTech Health X
  • December 15, 2024
Lexicon Pharmaceuticals, Inc. (LXRX), founded in 1995 and headquartered in The Woodlands, Texas, is a clinical-stage biopharmaceutical company…
0 Shares
0
0
0
0
0
0
0

Biotech NewsMersana (MRSN) Leverages Partnerships with Johnson & Johnson (JNJ), Merck (MRK) to Advance ADCs

  • BioTech Health X
  • December 14, 2024
Mersana Therapeutics Inc. (MRSN) is a clinical-stage biopharmaceutical company leading the way in the development of novel antibody-drug…
0 Shares
0
0
0
0
0
0
0

Biotech NewsAditxt (ADTX)’s $32.7M Investment Fuels Growth in the $84B Autoimmune Disease Market

  • BioTech Health X
  • December 12, 2024
Aditxt Inc. (ADTX) is revolutionizing the healthcare landscape with its focus on immune system reprogramming and precision health…
0 Shares
0
0
0
0
0
0
0
COVID-19 Rocks Yankees, 8th Vaccinated Member to Test Positive - Virology Experts Weigh In

Biotech NewsCorvus (CRVS) Shows Financial Resilience with $41.7M Cash and Strategic R&D Investments

  • BioTech Health X
  • December 7, 2024
Corvus Pharmaceuticals Inc. (CRVS) is a clinical-stage biopharmaceutical company dedicated to transforming the treatment landscape for cancer and…
0 Shares
0
0
0
0
0
0
0

Biotech NewsAvidity Biosciences (RNA): Strengthened by $1.6 Billion Cash Position and Strategic Partnerships

  • BioTech Health X
  • December 6, 2024
Avidity Biosciences Inc. (RNA) is a pioneering biopharmaceutical company revolutionizing the field of RNA therapeutics. Through its proprietary…
0 Shares
0
0
0
0
0
0
0
The Future of Genomics: GeneDx (WGS) Achieves Profitability & Expands Market Reach

Biotech NewsThe Future of Genomics: GeneDx (WGS) Achieves Profitability & Expands Market Reach

  • BioTech Health X
  • December 5, 2024
GeneDx Holdings Corp. (WGS) is a pioneering leader in the genomic diagnostics industry, dedicated to transforming healthcare through…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • Should You Now Start Buying Summit Therapeutics (SMMT) Shares Before its Too Late?
  • Is Legend Biotech (LEGN) a Great Investment Option?
  • Is it Still Safe to Invest in Soleno Therapeutics (SLNO)?
  • Should You Now Start Buying Corcept Therapeutics (CORT) Shares?
  • Is it a Wise Move to Invest in Ultragenyx Pharmaceutical (RARE)?
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • March 8, 2026
    Should You Now Start Buying Summit Therapeutics (SMMT) Shares Before its Too Late?
    • March 8, 2026
    Is Legend Biotech (LEGN) a Great Investment Option?
    • March 8, 2026
    Is it Still Safe to Invest in Soleno Therapeutics (SLNO)?
    • March 8, 2026
    Should You Now Start Buying Corcept Therapeutics (CORT) Shares?
    • March 8, 2026
    Is it a Wise Move to Invest in Ultragenyx Pharmaceutical (RARE)?
Recent Posts
  • Is it a Good Time to Acquire Wave Life Sciences (WVE) Shares?
    • March 8, 2026
  • Is Dyne Therapeutics (DYN) a Smart Long-Term Buy?
    • March 8, 2026
  • Is it a Smart Move to Buy Vaxcyte (PCVX) Shares?
    • March 8, 2026
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (5)
  • Biotech News (820)
  • Uncategorized (2)
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top